Last reviewed · How we verify
Pulmonary Mycobacterium avium complex infection
Approved treatments
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Trecator · Pfizer
- Biaxin · Generic (originally Abbott/AbbVie)
Clarithromycin is a macrolide antimicrobial drug. - Mycobutin · Harriet Shezi Children's Clinic
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary Mycobacterium avium complex infection patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary Mycobacterium avium complex infection treatment landscape brief
- Pulmonary Mycobacterium avium complex infection treatment updates RSS
Frequently asked questions about Pulmonary Mycobacterium avium complex infection
What drugs treat Pulmonary Mycobacterium avium complex infection?
Tracked treatments include Zithromax, Trecator, Biaxin, Mycobutin.
What is the treatment for Pulmonary Mycobacterium avium complex infection?
Standard treatment for Pulmonary Mycobacterium avium complex infection includes Zithromax, Trecator, Biaxin, Mycobutin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pulmonary Mycobacterium avium complex infection patent cliff · Pulmonary Mycobacterium avium complex infection CI report
- Treatment: Zithromax · Pfizer Inc.
- Treatment: Trecator · Pfizer
- Treatment: Biaxin · Generic (originally Abbott/AbbVie)
- Treatment: Mycobutin · Harriet Shezi Children's Clinic
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing